Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A coordinated effort to incorporate advances in the understanding of the molecular and genomic variations in common diseases, such as hypertension, into their diagnosis and treatment could transform drug development and medicine.

Original publication

DOI

10.1038/nrd3534

Type

Journal article

Journal

Nature reviews. Drug discovery

Publication Date

09/2011

Volume

10

Pages

641 - 642

Addresses

UCB Pharma and New Medicines, UCB, Anderlicht, Brussels, Belgium. ismail.kola@ucb.com

Keywords

Disease, Genomics, Molecular Biology, Research Design, Drug Industry, Classification, Clinical Trials as Topic